pharm-analyt bioanalytics We are an independent CRO specializing in bioanalytics during preclinical and clinical phases. GLP approved since 1992.As an independent partner, we aim to help pharmaceutical companies enhance speed of development and knowledge of new chemical entities (NCE). From Phases I to III, we assist large and smaller companies in all questions of analytics – from NCE to metabolites (also narcotic drugs), from protein binding to tissue or liquor penetration. Our sponsors profit from our extensive, in-depth knowledge of pharmaceutical development processes, bioanalytics and pharmacokinetics.